Please use this identifier to cite or link to this item: http://gukir.inflibnet.ac.in:8080/jspui/handle/123456789/4980
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMruthyunmyaswamy B.H.M
dc.contributor.authorHiremath B
dc.contributor.authorMalipatail S.M
dc.contributor.authorRaju S.A.
dc.date.accessioned2020-06-12T15:05:52Z-
dc.date.available2020-06-12T15:05:52Z-
dc.date.issued2007
dc.identifier.citationAsian Journal of Chemistry , Vol. 19 , 5 , p. 3775 - 3779en_US
dc.identifier.urihttp://gukir.inflibnet.ac.in:8080/jspui/handle/123456789/4980-
dc.description.abstractThree new simple, sensitive, selective and economical methods (A, B and C) have been developed for the quantitative estimation of cefetamet pivoxil in bulk and its pharmaceutical formulations. Method A is based on the formation of pink coloured chromoges obtained when drug was dizotised with nitrous acid followed by coupling the resulting diazonium salt with diphenylamine exhibiting ?max at 521 nm. Method B is based on the redox reaction of drug with PolinCiocalteau (FC) reagent exhibiting ?max at 675.5 nm. Method C is based on the formation of coloured Schiff base obtained when drug reacted with PDAB (p-dimethylamino-benzaldehyde) to form yellow coloured chromogen exhibiting ?max at 411 nm. These methods obeyed Beer's law in the concentration range of 10-50, 5-25 and 20-100 ?g/mL, respectively. The results of analysis for the 3 methods have been validated statistically and by recovery studies. The results are comparable with those obtained with UV spectrophotometeric method in double distilled water at ?max 234 nm.en_US
dc.subjectCefetamet piovxil
dc.subjectDiphenylamine
dc.subjectFolin-ciocalteau
dc.subjectP-Dimethylaminobenzaldehyde
dc.subjectSpectrophotometry
dc.titleSpectrophotometric estimation of cefetamet pivoxil in pharmaceutical formulationsen_US
dc.typeArticle
Appears in Collections:1. Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.